메뉴 건너뛰기




Volumn 19, Issue 1, 2013, Pages 120-128

Secondary causes of osteoporosis

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALENDRONIC ACID; ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; AROMATASE INHIBITOR; CALCIUM; CREATININE; DENOSUMAB; ELECTROLYTE; GLUCOCORTICOID; GONADORELIN AGONIST; HEPARIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LITHIUM; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PARATHYROID HORMONE; PHOSPHORUS; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SODIUM; TESTOSTERONE; THYROID HORMONE; THYROTROPIN; WARFARIN; ZOLEDRONIC ACID;

EID: 84881493131     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12059.RA     Document Type: Review
Times cited : (59)

References (81)
  • 2
    • 0035857351 scopus 로고    scopus 로고
    • Osteoporosis prevention, diagnosis, and therapy
    • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
    • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
    • (2001) JAMA , vol.285 , pp. 785-795
  • 6
    • 79952394479 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis
    • Watts N, Bilezikian J, Camacho P, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16 (Suppl 3):1-37.
    • (2010) Endocr Pract , vol.16 , Issue.SUPPL. 3 , pp. 1-37
    • Watts, N.1    Bilezikian, J.2    Camacho, P.3
  • 10
    • 0034700316 scopus 로고    scopus 로고
    • Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa
    • Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000;133:790-794.
    • (2000) Ann Intern Med , vol.133 , pp. 790-794
    • Grinspoon, S.1    Thomas, E.2    Pitts, S.3
  • 11
    • 0033774210 scopus 로고    scopus 로고
    • The physiology of the highly trained female endurance runner
    • Burrows M, Bird S. The physiology of the highly trained female endurance runner. Sports Med. 2000;30:281-300.
    • (2000) Sports Med , vol.30 , pp. 281-300
    • Burrows, M.1    Bird, S.2
  • 12
    • 0036738484 scopus 로고    scopus 로고
    • Abnormal bone mineral accrual in adolescent girls with anorexia nervosa
    • Soyka LA, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002;87:4177-4185.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4177-4185
    • Soyka, L.A.1    Misra, M.2    Frenchman, A.3
  • 13
    • 77952828166 scopus 로고    scopus 로고
    • Anorexia nervosa, osteoporosis and circulating leptin: The missing link
    • Legroux I, Pigny B, Vignau J, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteo International. 2010;21:1715-1722.
    • (2010) Osteo International , vol.21 , pp. 1715-1722
    • Legroux, I.1    Pigny, B.2    Vignau, J.3
  • 14
    • 0027051476 scopus 로고
    • Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise
    • Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res. 1992;7:1467-1474. (Pubitemid 23007093)
    • (1992) Journal of Bone and Mineral Research , vol.7 , Issue.12 , pp. 1467-1474
    • Seeman, E.1    Szmukler, G.I.2    Formica, C.3    Tsalamandris, C.4    Mestrovic, R.5
  • 15
    • 79960082236 scopus 로고    scopus 로고
    • Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study
    • Miller K, Meenaghan E, Lawson E, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011;96:2081-2088.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 2081-2088
    • Miller, K.1    Meenaghan, E.2    Lawson, E.3
  • 16
    • 77952115101 scopus 로고    scopus 로고
    • Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women
    • Gray S, LaCroix A, Larson J, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women. Arch Intern Med. 2010;170:765-771.
    • (2010) Arch Intern Med , vol.170 , pp. 765-771
    • Gray, S.1    LaCroix, A.2    Larson, J.3
  • 18
    • 7944235860 scopus 로고    scopus 로고
    • Fracture risk associated with use of antiepileptic drugs
    • DOI 10.1111/j.0013-9580.2004.18804.x
    • Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of epileptic drugs. Epilepsia. 2004;45:1330-1337. (Pubitemid 39470036)
    • (2004) Epilepsia , vol.45 , Issue.11 , pp. 1330-1337
    • Vestergaard, P.1    Rejnmark, L.2    Mosekilde, L.3
  • 20
    • 0027467168 scopus 로고
    • Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
    • Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 1894 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993;168:1265-1270. (Pubitemid 23122178)
    • (1993) American Journal of Obstetrics and Gynecology , vol.168 , Issue.4 , pp. 1265-1270
    • Dahlman, T.C.1
  • 23
    • 0025101215 scopus 로고
    • Glucocorticoid-induced osteoporosis: Pathogenesis and management
    • Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352-364. (Pubitemid 20083611)
    • (1990) Annals of Internal Medicine , vol.112 , Issue.5 , pp. 352-364
    • Lukert, B.P.1    Raisz, L.G.2
  • 26
    • 0033498501 scopus 로고    scopus 로고
    • Risedronate therapy prevents corticosteroid-induced bone loss: A twelve month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
    • Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 1999;42:2309-1238.
    • (1999) Arthritis Rheum , vol.42 , pp. 2309-11238
    • Cohen, S.1    Levy, R.M.2    Keller, M.3
  • 27
    • 64049104797 scopus 로고    scopus 로고
    • Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): A multicenter, double-blind, double-dummy, randomized controlled trial
    • Reid DM, Devogelaer JP, Saag K, et al. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicenter, double-blind, double-dummy, randomized controlled trial. Lancet. 2009;373:1253-1263.
    • (2009) Lancet , vol.373 , pp. 1253-1263
    • Reid, D.M.1    Devogelaer, J.P.2    Saag, K.3
  • 29
    • 79951581065 scopus 로고    scopus 로고
    • American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
    • Grossman J, Gordon R, Ranganath V, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-1526.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 1515-1526
    • Grossman, J.1    Gordon, R.2    Ranganath, V.3
  • 33
    • 33947732766 scopus 로고    scopus 로고
    • Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: A randomized trial
    • Greenspan SL, Nelson JB, Trump DL, Resnick NM. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer. Ann Int Med. 2007;146:416-424. (Pubitemid 351650576)
    • (2007) Annals of Internal Medicine , vol.146 , Issue.6 , pp. 416-424
    • Greenspan, S.L.1    Nelson, J.B.2    Trump, D.L.3    Resnick, N.M.4    Miller, M.5
  • 35
    • 69049105440 scopus 로고    scopus 로고
    • Denosumab in men receiving androgen-deprivation therapy for prostate cancer
    • Smith MR, Egerdie B, Hernández Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009;361:745-755.
    • (2009) N Engl J Med , vol.361 , pp. 745-755
    • Smith, M.R.1    Egerdie, B.2    Hernández Toriz, N.3
  • 36
    • 77956635018 scopus 로고    scopus 로고
    • Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: A matched cohort study of 19,079 men
    • Alibhai SM, Duong-Hua M, Cheung AM, et al. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: A matched cohort study of 19,079 men. J Urol. 2010;184:918-924.
    • (2010) J Urol , vol.184 , pp. 918-924
    • Alibhai, S.M.1    Duong-Hua, M.2    Cheung, A.M.3
  • 37
    • 0037157603 scopus 로고    scopus 로고
    • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial
    • DOI 10.1016/S0140-6736(02)09088-8
    • Baum M, Budzar AU, Cuzick J, et al. Anastrazole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet. 2002;359:2131-2139. (Pubitemid 34694019)
    • (2002) Lancet , vol.359 , Issue.9324 , pp. 2131-2139
    • Baum, M.1    Buzdar, A.U.2    Cuzick, J.3    Forbes, J.4    Houghton, J.5    Klijn, J.G.M.6    Sahmoud, T.7
  • 38
    • 33947524592 scopus 로고    scopus 로고
    • Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer
    • Brufsky A, Harker WG, Beck JT, et al. Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. J Clin Oncol. 2007;25:829.
    • (2007) J Clin Oncol , vol.25 , pp. 829
    • Brufsky, A.1    Harker, W.G.2    Beck, J.T.3
  • 39
    • 39749155815 scopus 로고    scopus 로고
    • Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results
    • Bundred NJ, Campbell ID, Davidson N, et al. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Cancer. 2008;112:1001.
    • (2008) Cancer , vol.112 , pp. 1001
    • Bundred, N.J.1    Campbell, I.D.2    Davidson, N.3
  • 40
    • 77949900992 scopus 로고    scopus 로고
    • Prevention of aromatase inhibitor-induced bone loss using risedronate: The SABRE trial
    • Van Poznak C, Hannon RA, Mackey JR, et al. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol. 2010;28:967-975.
    • (2010) J Clin Oncol , vol.28 , pp. 967-975
    • Van Poznak, C.1    Hannon, R.A.2    Mackey, J.R.3
  • 41
    • 54449084015 scopus 로고    scopus 로고
    • Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer
    • Ellis GK, Bone HG, Chlebowski R, et al. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008;26:4875-4882.
    • (2008) J Clin Oncol , vol.26 , pp. 4875-4882
    • Ellis, G.K.1    Bone, H.G.2    Chlebowski, R.3
  • 42
    • 78049526466 scopus 로고    scopus 로고
    • Use of repot medroxyprogesterone acetate and gracture risk
    • Meier C, Brauchli Y, Jick S, et al. Use of repot medroxyprogesterone acetate and gracture risk. J Clin Endocrinol Metab. 2010;95:4909-4916.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 4909-4916
    • Meier, C.1    Brauchli, Y.2    Jick, S.3
  • 44
    • 0030774682 scopus 로고    scopus 로고
    • Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause
    • Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Lund del Castillo JD. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause. Clin Endocrinol (Oxf). 1997;47:279-285. (Pubitemid 27395958)
    • (1997) Clinical Endocrinology , vol.47 , Issue.3 , pp. 279-285
    • Jodar, E.1    Munoz-Torres, M.2    Escobar-Jimenez, F.3    Quesada-Charneco, M.4    Luna, D.C.J.D.5
  • 47
    • 79955666598 scopus 로고    scopus 로고
    • The thyroid epidemiology, audit, and research study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism
    • Vadiveloo T, Donnan P, Cochrane L, Leese G. The thyroid epidemiology, audit, and research study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011;96:1344-1351.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1344-1351
    • Vadiveloo, T.1    Donnan, P.2    Cochrane, L.3    Leese, G.4
  • 50
    • 0034889433 scopus 로고    scopus 로고
    • Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
    • DOI 10.1210/er.22.4.477
    • Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501. (Pubitemid 32762324)
    • (2001) Endocrine Reviews , vol.22 , Issue.4 , pp. 477-501
    • Lips, P.1
  • 51
    • 0035048979 scopus 로고    scopus 로고
    • A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial
    • DOI 10.1210/jc.86.3.1212
    • Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab. 2001;86:1212-1221. (Pubitemid 32323007)
    • (2001) Journal of Clinical Endocrinology and Metabolism , vol.86 , Issue.3 , pp. 1212-1221
    • Lips, P.1    Duong, T.2    Oleksik, A.3    Black, D.4    Cummings, S.5    Cox, D.6    Nickelsen, T.7
  • 52
    • 79960104336 scopus 로고    scopus 로고
    • Endocrine Society Task Force. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine soci ety clinical practice guideline
    • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society Task Force. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine soci ety clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1911-1930
    • Holick, M.F.1    Binkley, N.C.2    Bischoff-Ferrari, H.A.3
  • 53
    • 78650886291 scopus 로고    scopus 로고
    • The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know
    • Ross AC, Manson J, Abrams S, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 53-58
    • Ross, A.C.1    Manson, J.2    Abrams, S.3
  • 54
    • 0034279541 scopus 로고    scopus 로고
    • Skeletal effects of primary hyperparathyroidism
    • Syed Z, Khan A. Skeletal effects of primary hyperparathyroidism. Endocr Pract. 2000;6:385-388.
    • (2000) Endocr Pract , vol.6 , pp. 385-388
    • Syed, Z.1    Khan, A.2
  • 55
    • 0034713771 scopus 로고    scopus 로고
    • Primary hyperparathyroidism: Pathophysiology and impact on bone
    • Khan A, Bilezikian J. Primary hyperparathyroidism: Pathophysiology and impact on bone. CMAJ. 2000;163:184-187. (Pubitemid 30625659)
    • (2000) Canadian Medical Association Journal , vol.163 , Issue.2 , pp. 184-187
    • Khan, A.1    Bilezikian, J.2
  • 57
    • 0033592750 scopus 로고    scopus 로고
    • A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
    • DOI 10.1056/NEJM199910213411701
    • Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-1255. (Pubitemid 29489739)
    • (1999) New England Journal of Medicine , vol.341 , Issue.17 , pp. 1249-1255
    • Silverberg, S.J.1    Shane, E.2    Jacobs, T.P.3    Siris, E.4    Bilezikian, J.P.5
  • 58
    • 0042878414 scopus 로고    scopus 로고
    • Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism
    • Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003;327:530-534.
    • (2003) BMJ , vol.327 , pp. 530-534
    • Vestergaard, P.1    Mosekilde, L.2
  • 60
    • 0142228231 scopus 로고    scopus 로고
    • Osteoporosis after solid organ and bone marrow transplantation
    • DOI 10.1007/s00198-003-1426-z
    • Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int. 2003;14:617-630. (Pubitemid 41490345)
    • (2003) Osteoporosis International , vol.14 , Issue.8 , pp. 617-630
    • Cohen, A.1    Shane, E.2
  • 65
    • 0033979309 scopus 로고    scopus 로고
    • Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis
    • DOI 10.1046/j.1365-2796.2000.00582.x
    • Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000;247:63-70. (Pubitemid 30073165)
    • (2000) Journal of Internal Medicine , vol.247 , Issue.1 , pp. 63-70
    • Ardizzone, S.1    Bollani, S.2    Bettica, P.3    Bevilacqua, M.4    Molteni, P.5    Porro, G.B.6
  • 67
    • 14044258690 scopus 로고    scopus 로고
    • Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis
    • DOI 10.1001/archinte.165.4.393
    • Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med. 2005;165:393-399. (Pubitemid 40280193)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.4 , pp. 393-399
    • Stenson, W.F.1    Newberry, R.2    Lorenz, R.3    Baldus, C.4    Civitelli, R.5
  • 68
  • 69
    • 0029040649 scopus 로고
    • A controlled study of bone mineral density in patients with inflammatory bowel disease
    • Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995;37:71-76.
    • (1995) Gut , vol.37 , pp. 71-76
    • Silvennoinen, J.A.1    Karttunen, T.J.2    Niemela, S.E.3    Manelius, J.J.4    Lehtola, J.K.5
  • 70
    • 78549261031 scopus 로고    scopus 로고
    • Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major
    • Baldini M, Forti, S. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol. 2010;89:1207-1213.
    • (2010) Ann Hematol , vol.89 , pp. 1207-1213
    • Baldini, M.1    Forti, S.2
  • 72
    • 77957960294 scopus 로고    scopus 로고
    • Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: A population-based study
    • Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood. 2010;116:2651-2655.
    • (2010) Blood , vol.116 , pp. 2651-2655
    • Kristinsson, S.Y.1    Tang, M.2    Pfeiffer, R.M.3
  • 76
    • 0028857530 scopus 로고
    • Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol
    • Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50-59.
    • (1995) Am J Med , vol.98 , pp. 50-59
    • Levy, F.L.1    Adams-Huet, B.2    Pak, C.Y.3
  • 78
  • 80
    • 0141797417 scopus 로고    scopus 로고
    • Thiazide diuretics and the risk for hip fracture
    • Mariette W, Schoofs C, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476-482.
    • (2003) Ann Intern Med , vol.139 , pp. 476-482
    • Mariette, W.1    Schoofs, C.2    Hofman, A.3
  • 81
    • 21344472317 scopus 로고    scopus 로고
    • Reduced fracture risk in users of thiazide diuretics
    • DOI 10.1007/s00223-004-0084-2
    • Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int. 2005;76:167-175. (Pubitemid 41557145)
    • (2005) Calcified Tissue International , vol.76 , Issue.3 , pp. 167-175
    • Rejnmark, L.1    Vestergaard, P.2    Mosekilde, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.